BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34746121)

  • 21. Aberrant axon branching via Fos-B dysregulation in FUS-ALS motor neurons.
    Akiyama T; Suzuki N; Ishikawa M; Fujimori K; Sone T; Kawada J; Funayama R; Fujishima F; Mitsuzawa S; Ikeda K; Ono H; Shijo T; Osana S; Shirota M; Nakagawa T; Kitajima Y; Nishiyama A; Izumi R; Morimoto S; Okada Y; Kamei T; Nishida M; Nogami M; Kaneda S; Ikeuchi Y; Mitsuhashi H; Nakayama K; Fujii T; Warita H; Okano H; Aoki M
    EBioMedicine; 2019 Jul; 45():362-378. PubMed ID: 31262712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis.
    Pokrishevsky E; Grad LI; Yousefi M; Wang J; Mackenzie IR; Cashman NR
    PLoS One; 2012; 7(4):e35050. PubMed ID: 22493728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis.
    Deng HX; Zhai H; Bigio EH; Yan J; Fecto F; Ajroud K; Mishra M; Ajroud-Driss S; Heller S; Sufit R; Siddique N; Mugnaini E; Siddique T
    Ann Neurol; 2010 Jun; 67(6):739-48. PubMed ID: 20517935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging.
    Japtok J; Lojewski X; Naumann M; Klingenstein M; Reinhardt P; Sterneckert J; Putz S; Demestre M; Boeckers TM; Ludolph AC; Liebau S; Storch A; Hermann A
    Neurobiol Dis; 2015 Oct; 82():420-429. PubMed ID: 26253605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abundant FUS-immunoreactive pathology in the skin of sporadic amyotrophic lateral sclerosis.
    Oketa Y; Higashida K; Fukasawa H; Tsukie T; Ono S
    Acta Neurol Scand; 2013 Oct; 128(4):257-64. PubMed ID: 23448665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenoviral expression of TDP-43 and FUS genes and shRNAs for protein degradation pathways in rodent motoneurons in vitro and in vivo.
    Watabe K; Akiyama K; Kawakami E; Ishii T; Endo K; Yanagisawa H; Sango K; Tsukamoto M
    Neuropathology; 2014 Feb; 34(1):83-98. PubMed ID: 23937386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening of SOD1, FUS and TARDBP genes in patients with amyotrophic lateral sclerosis in central-southern China.
    Hou L; Jiao B; Xiao T; Zhou L; Zhou Z; Du J; Yan X; Wang J; Tang B; Shen L
    Sci Rep; 2016 Sep; 6():32478. PubMed ID: 27604643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Motor neuron apoptosis and neuromuscular junction perturbation are prominent features in a Drosophila model of Fus-mediated ALS.
    Xia R; Liu Y; Yang L; Gal J; Zhu H; Jia J
    Mol Neurodegener; 2012 Mar; 7():10. PubMed ID: 22443542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis.
    Sabatelli M; Moncada A; Conte A; Lattante S; Marangi G; Luigetti M; Lucchini M; Mirabella M; Romano A; Del Grande A; Bisogni G; Doronzio PN; Rossini PM; Zollino M
    Hum Mol Genet; 2013 Dec; 22(23):4748-55. PubMed ID: 23847048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autophagy regulates amyotrophic lateral sclerosis-linked fused in sarcoma-positive stress granules in neurons.
    Ryu HH; Jun MH; Min KJ; Jang DJ; Lee YS; Kim HK; Lee JA
    Neurobiol Aging; 2014 Dec; 35(12):2822-2831. PubMed ID: 25216585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ALS mutations in TLS/FUS disrupt target gene expression.
    Coady TH; Manley JL
    Genes Dev; 2015 Aug; 29(16):1696-706. PubMed ID: 26251528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficient RNA-editing enzyme ADAR2 in an amyotrophic lateral sclerosis patient with a FUS(P525L) mutation.
    Aizawa H; Hideyama T; Yamashita T; Kimura T; Suzuki N; Aoki M; Kwak S
    J Clin Neurosci; 2016 Oct; 32():128-9. PubMed ID: 27343041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutant FUS induces endoplasmic reticulum stress in amyotrophic lateral sclerosis and interacts with protein disulfide-isomerase.
    Farg MA; Soo KY; Walker AK; Pham H; Orian J; Horne MK; Warraich ST; Williams KL; Blair IP; Atkin JD
    Neurobiol Aging; 2012 Dec; 33(12):2855-68. PubMed ID: 22459602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein arginine methyltransferase 1 and 8 interact with FUS to modify its sub-cellular distribution and toxicity in vitro and in vivo.
    Scaramuzzino C; Monaghan J; Milioto C; Lanson NA; Maltare A; Aggarwal T; Casci I; Fackelmayer FO; Pennuto M; Pandey UB
    PLoS One; 2013; 8(4):e61576. PubMed ID: 23620769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates FUS toxicity.
    Daigle JG; Krishnamurthy K; Ramesh N; Casci I; Monaghan J; McAvoy K; Godfrey EW; Daniel DC; Johnson EM; Monahan Z; Shewmaker F; Pasinelli P; Pandey UB
    Acta Neuropathol; 2016 Apr; 131(4):605-20. PubMed ID: 26728149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN.
    Groen EJ; Fumoto K; Blokhuis AM; Engelen-Lee J; Zhou Y; van den Heuvel DM; Koppers M; van Diggelen F; van Heest J; Demmers JA; Kirby J; Shaw PJ; Aronica E; Spliet WG; Veldink JH; van den Berg LH; Pasterkamp RJ
    Hum Mol Genet; 2013 Sep; 22(18):3690-704. PubMed ID: 23681068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules.
    Bosco DA; Lemay N; Ko HK; Zhou H; Burke C; Kwiatkowski TJ; Sapp P; McKenna-Yasek D; Brown RH; Hayward LJ
    Hum Mol Genet; 2010 Nov; 19(21):4160-75. PubMed ID: 20699327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative proteomics identifies proteins that resist translational repression and become dysregulated in ALS-FUS.
    Baron DM; Matheny T; Lin YC; Leszyk JD; Kenna K; Gall KV; Santos DP; Tischbein M; Funes S; Hayward LJ; Kiskinis E; Landers JE; Parker R; Shaffer SA; Bosco DA
    Hum Mol Genet; 2019 Jul; 28(13):2143-2160. PubMed ID: 30806671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FUS is sequestered in nuclear aggregates in ALS patient fibroblasts.
    Schwartz JC; Podell ER; Han SS; Berry JD; Eggan KC; Cech TR
    Mol Biol Cell; 2014 Sep; 25(17):2571-8. PubMed ID: 25009283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wild-Type and Mutant FUS Expression Reduce Proliferation and Neuronal Differentiation Properties of Neural Stem Progenitor Cells.
    Stronati E; Biagioni S; Fiore M; Giorgi M; Poiana G; Toselli C; Cacci E
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.